Sabotage as therapy: Aiming lupus antibodies at vulnerable cancer cells

(Yale University) Yale Cancer Center researchers may have discovered a new way of harnessing lupus antibodies to sabotage cancer cells made vulnerable by deficient DNA repair.The study, led by James E. Hansen, M.D., assistant professor of therapeutic radiology at Yale School of Medicine, found that cancer cells with deficient DNA repair mechanisms (or the inability to repair their own genetic damage) were significantly more vulnerable to attack by lupus antibodies.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news